Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (431-440 of 542) with videos related to

Pageof 55
Sort By:
Diagnostic Microbiology and Infectious Disease|November 14, 1997
Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance programW W Wilke, S A Marshall, S L Coffman, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller, D J Diekema, M Mendez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1992
Restriction endonuclease analysis of Staphylococcus aureus plasmid DNA from three continentsB N Doebbeling, M A Pfaller, R J Hollis, et al.
Journal of Clinical Microbiology|January 9, 2003
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformansT Yamazumi, M A Pfaller, S A Messer, et al.
Journal of Clinical Microbiology|June 29, 2002
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithmS S Richter, S E Beekmann, J L Croco, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2011
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)A Espinel-Ingroff, M Cuenca-Estrella, A Fothergill, et al.
The Journal of Infectious Diseases|October 1, 1988
Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infectionsR M Massanari, M A Pfaller, D S Wakefield, et al.
Journal of Clinical Microbiology|March 30, 2002
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms studyD J Diekema, S A Messer, A B Brueggemann, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology|January 14, 2011
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff valuesM A Pfaller, A Espinel-Ingroff, L Boyken, et al.
Pageof 55

Showing results (431-440 of 542) with videos related to

Sort By:
Pageof 55
Diagnostic Microbiology and Infectious Disease|November 14, 1997
Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance programW W Wilke, S A Marshall, S L Coffman, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller, D J Diekema, M Mendez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1992
Restriction endonuclease analysis of Staphylococcus aureus plasmid DNA from three continentsB N Doebbeling, M A Pfaller, R J Hollis, et al.
Journal of Clinical Microbiology|January 9, 2003
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformansT Yamazumi, M A Pfaller, S A Messer, et al.
Journal of Clinical Microbiology|June 29, 2002
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithmS S Richter, S E Beekmann, J L Croco, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2011
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)A Espinel-Ingroff, M Cuenca-Estrella, A Fothergill, et al.
The Journal of Infectious Diseases|October 1, 1988
Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infectionsR M Massanari, M A Pfaller, D S Wakefield, et al.
Journal of Clinical Microbiology|March 30, 2002
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms studyD J Diekema, S A Messer, A B Brueggemann, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology|January 14, 2011
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff valuesM A Pfaller, A Espinel-Ingroff, L Boyken, et al.
Pageof 55